We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Agilent’s Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference
Product News

Agilent’s Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference

Agilent’s Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference
Product News

Agilent’s Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Agilent’s Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Stratagene, an Agilent Technologies Inc. company, announced it has launched an expanded line of quantitative PCR reagents with enhanced sensitivity of detection. This new line of Brilliant II QPCR and QRT-PCR reagents was developed specifically to provide improved performance on the Stratagene Mx systems. The launch of Brilliant II is the first major product introduction by Stratagene since Agilent acquired the company in 2007.

Brilliant II reagents offer improved performance with earlier threshold cycle (Ct) detection across a wide dynamic range. The reagents utilize a streamlined protocol to increase speed to result. The expanded product line includes Brilliant II QPCR, One- and Two-Step QRT-PCR for use with probes and SYBR Green, and Brilliant II ROX master mix in both low- and high-ROX formulations.

The product line also includes the Stratagene High-Specificity miRNA QRT-PCR detection kit that provides single nucleotide discrimination within and among microRNA (miRNA) families. MiRNAs are small, non-coding RNA molecules that are estimated to regulate at least 30 percent of all protein-encoding genes. MiRNAs have been implicated in development, differentiation, apoptosis, viral infection and cancer.

“The Stratagene name has long been recognized for innovation in the life science industry,” said Bill Molnar, vice president and general manager, Stratagene branded products. “Agilent’s extensive portfolio, particularly in microarrays and other oligo synthesis capabilities, is taking our product offerings to the next level.”

Stratagene is a leading reagent manufacturer and holds an extensive patent portfolio in the development of innovative reagents and kits. Stratagene’s products are used by global life science research laboratories and medical researchers to detect and measure biological processes.

“Our new reagents were developed to maintain the high quality of Stratagene’s original Brilliant product line,” said Rena McClory, senior director of marketing, Stratagene branded products. “The new formulation offers customers improved performance for both routine and demanding real-time PCR applications.”

Last week Agilent introduced three new microRNA microarray designs: Human miRNA Microarray v2.0, Mouse miRNA Microarray v1.0 and Rat miRNA Microarray v1.0. All are based on the Sanger Institute’s miRBase 10.1, updated in December 2007.

Advertisement